Log In
Print this Print this

rabeximod (formerly Rob 803)

  Manage Alerts
Collapse Summary General Information
Company OxyPharma AB
DescriptionAnti-inflammatory small molecule that supresses the differentiation of monocytes into pro-inflammatory macrophages
Molecular Target Undisclosed
Mechanism of ActionUndisclosed
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationRheumatoid arthritis (RA)
Indication DetailsTreat moderate or severe active rheumatoid arthritis (RA); Treat rheumatoid arthritis (RA)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today